Official Name: Roche Holding AG
Headquarters: Basel, Switzerland
CEO: Dr. Severin Schwan Ph.D.
CHF as of July 1, 2023
Roche is a global healthcare company involved in prescription pharmaceuticals and diagnostics. It offers pharmaceutical products for a range of medical conditions, including oncology, neuroscience, infectious diseases, immunology, and ophthalmology. It also provides in vitro diagnostics solutions for several indications, supplies diagnostic instruments, reagents, consumables, and test kits for research, and collaborates with other companies for drug development.
|Company||Market Cap (USD)|
|Johnson & Johnson||$412.24 B|
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, the company supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. It has collaboration with Gilead Sciences, Inc. for COVID-19; and a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!
Roche Holding AG has the following listings and related stock indices.
Prescription pharmaceuticals, In vitro diagnostics, Oncology products, Neuroscience products, Infectious disease products, Immunology products, Cardiovascular and metabolism products, Ophthalmology products, Respiratory products, Research equipment and supplies